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RAS proteins act as molecular switches transmitting sig-
nals from the cell surface to the nucleus, thereby affecting
several downstream signaling cascades. Among these cas-
cades, the mitogenic MEK/ERK pathway affects a network
of transcription factors such as SRF, ELK and AP1 compo-
nents, largely known to play an important role in regulat-
ing cellular proliferation. While the targets of individual
transcription factors have been identified, the structure of
the transcription factor network down-stream of MEK/
ERK signaling mediating transformation is not well
understood. In addition, both gene activation and repres-
sion are necessary for tumor formation and it is unclear
how certain MEK/ERK stimulated transcription factors
participate in both processes.
We performed genome-wide gene expression analysis to
identify transcription factors differentially regulated via
MEK/ERK between immortalized and HRAS-transformed
cells. Individual transcription factors such as Fra1, over-
expressed in RAS-transformed cells and human tumors
derived from lung or bone, were knocked-down using
siRNA. A second gene expression profiling was used to
determine the target genes of these transcription factors.
TRAP (TRanscription factor Affinity Prediction), a bio-
physical model of transcription factor binding and gene
set enrichment analysis (GSEA) was used to screen for
genes with conserved binding motifs and for functional
gene sets exhibiting similar regulation.
These approaches revealed novel insights into the role of
Fra1 upon activation in RAS-transformed cells. We could
define a previously unknown involvement of the MEK/
ERK-dependent Fra1 transcription factor in governing the
alteration of the transcriptional network in tumor cells:
Fra1 seems to play a role in chromatin remodeling and in
circadian functions. In addition, we observed a Fra1-
dependent suppression of interferon target genes, which
are known to be regulated via DNA methylation. These
data suggest a key role for the AP1 complex and the Fra1
transcription factor in the reorganization of chromatin
and the transcriptional network following oncogenic
transformation.
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